PharmaShots | Incisive News in 3 Shots

Subscribe Now

ProvidesTrials

Takeda Reports First Patients Dosing in P-I/II Study of Novavax's COVID-19 Vaccine Candidate in Japan

Takeda Reports First Patients Dosing in P-I/II Study of Novavax's COVID-19 Vaccine Candidate in Japan

February 24, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us